AssureRx Launches First Personalized Medicine Product
AssureRx Health Inc., a personalized medicine company, announced today that it has begun a full launch of its first product, GeneSightRx. This lab-developed, pharmacogenetic test had previously been commercially available only on a limited basis. The test combines state-of-the-art genetic testing technology with a multi-variate, algorithmic, interpretive report to help guide physicians during their decision-making process before prescribing psychiatric medications. Al Lucas, VP Sales and Marketing, stated, “There is a significant challenge in psychiatric medicine to quickly find the most appropriate medication for each individual patient, which may bring relief from symptoms, reduce or prevent hospitalization, and avoid sever side-effects. Until recently, doctors had no way of identifying patients who may have genetic variations that would affect how medications might work in each patient.”
Lucas went on to say, “GeneSightRx is a major advance in the field of Personalized Medicine. The results of the test are available in an easy-to-use, web based report. Doctors will have a new tool to help select medications for their patients.”
Each year over 25 million Americans are treated for a Mental Health Disorder, and over 200 million prescriptions for antidepressant medications filled. Yet, the failure rate for these medications can be as high as 50%. While there are many factors contributing to this high failure rate, there is a strong correlation between a patient’s genetic makeup and their individual response to drugs.
James S. Burns, President & CEO, commented, “The launch of GeneSightRx represents a major advance in the treatment of psychiatric disorders. For the first time, the prescribing of psychotropic medications can be tailored to the unique genetic fingerprint of each patient, providing an evidence-based solution to physicians concerning which drugs are potentially more effective or less toxic on a patient-by-patient basis. GeneSightRx brings cutting-edge pharmacogenetics technology developed at Mayo Clinic and Cincinnati Children’s Hospital Medical Center into routine clinical use.”
GeneSightRx is available by prescription only. It must be ordered by a physician. The results of the test are available in as little as 48 hours, and are strictly confidential. AssureRx is a CLIA-approved laboratory located in Mason, Ohio.
GeneSight is a laboratory developed pharmacogenomic test that uses cutting edge technology to measure and analyze clinically important genomic variants in the treatment of psychiatric disorders. The results of the GeneSight report can help a clinician understand the way a patient’s unique genomic makeup may affect certain psychiatric drugs. The analysis is based on pharmacogenomics, the study of genomic factors that influence an individual’s response to drug treatments, FDA approved manufacturer’s drug labels, peer-reviewed scientific and clinical publications, and proven drug pharmacology. Quick turnaround time, combined with a customized report of the patient’s genomic makeup, clinical experience and other factors can help a physician make personalized drug treatment choices for each patient.
About AssureRx Health, Inc.
AssureRx Health, Inc. is a personalized medicine company that specializes in pharmacogenomics dedicated to helping physicians determine the right drug for individual patients suffering from neuropsychiatric and other disorders. The company was founded to commercialize industry-leading personalized medicine technology for neuropsychiatric disorders. Mayo Clinic and Cincinnati Children’s Hospital Medical Center are equity holders and technology collaborators.